SUBSCRIBERS
Biolidics' Covid-19 rapid test kit allowed to be sold in EU
Vivienne Tay
Published Mon, Apr 6, 2020 · 09:50 PM
Singapore
SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).
This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
